21 U.S.C. § 202
REGISTRATION FOR THE COMMERCIAL PRODUCTION AND DISTRIBUTION OF FOOD AND DRUG ADMINISTRATION-APPROVED DRUGS.
“The Attorney General shall register an applicant to manufacture or distribute cannabidiol or marijuana for the purpose of commercial production of a drug containing or derived from marijuana that is approved by the Secretary of Health and Human Services under section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355), in accordance with the applicable requirements under subsection (a) or (b) of section 303 of the Controlled Substances Act (21 U.S.C. 823).”
Notes of Decisions
Cited in 2
cases, 2012–2013 · leading case: Evans v. Thomas Jefferson Univ., 81 A.3d 1062 (Pa. Commw. Ct. 2013).
Evans v. Thomas Jefferson Univ., 81 A.3d 1062 (Pa. Commw. Ct. 2013). “Evans had also originally contended that Vandegrift's conduct violated 21 U.S.C. § 202 . (Plaintiff's Response to Defendants' First Set of Interrogatories, Supp.”
Diamond Offshore Co. v. Survival Sys. Int'l, Inc., 902 F. Supp. 2d 912 (S.D. Tex. 2012). “(quoting 21 U.S.C. § 202 ). The drug manufacturer argued that there was a conflict because it could not comply with both the federal label requirements and state-law duties.”
Annotations are extracted automatically from the opinions in the
Syfert caselaw corpus and ranked by authority, recency, and
treatment. Dots show Syfertize treatment of the citing case itself.